chartexchange

NeOnc Technologies Announces FDA Rescheduled NEO212 End-of-Phase 1 Type B Meeting to November 23

GlobeNewswire Inc. | Nov 19, 2026 1:37 PM EST

NeOnc Technologies Announces FDA Rescheduled NEO212 End-of-Phase 1 Type B Meeting to November 23

Read original article